YUNYING CHEN: Open Payments
NPI 1558944520 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$32,435 in 81 payments from 15 companies in 2025. Trend: 2023 $17,213 · 2024 $29,794 · 2025 $32,435
Speaker / faculty: $14,765Travel & lodging: $6,576Consulting: $6,375Honoraria: $2,644Food & beverage: $2,032Education: $43
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 29 | $21,288 |
| Rigel Pharmaceuticals, Inc. | 11 | $7,890 |
| Autolus Inc | 4 | $2,159 |
| Janssen Biotech, Inc. | 20 | $512 |
| Incyte Corporation | 1 | $125 |
| Daiichi Sankyo Inc. | 4 | $111 |
| AstraZeneca Pharmaceuticals LP | 3 | $99 |
| ABBVIE INC. | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Secura Bio, Inc. | 1 | $30 |
Products named: ELREXFIO, REZLIDHIA, CARVYKTI, TALVEY, RYBREVANT, Niktimvo, Vanflyta, EPKINLY.
Industry payments across CA — which companies pay providers there.
